Endothelial dysfunction in rat adjuvant-induced arthritis: Up-regulation of the vascular arginase pathway

Arthritis and Rheumatism

Volumn 63, Issue 8, 2011, Pages 2309-2317

  Prati, Clément ^a   Berthelot, Alain ^a   Wendling, Daniel ^b   Demougeot, Céline ^a  

^a France   (France)

^b Hôpital Saint Jacques   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGINASE; ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROLASE INHIBITOR; INTERLEUKIN 6; N GAMMA HYDROXY NOR LEVO ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THORACIC AORTA; VASCULAR RING; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA; ARGINASE; ARTHRITIS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; INTERLEUKIN-6; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; NITROPRUSSIDE; NOREPINEPHRINE; RATS; RATS, INBRED LEW; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 79961104905     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30391     Document Type: Article

References (49)

1. Ciftci O, Yilmaz S, Topcu S, Caliskan M, Gullu H, Erdogan D, et al. Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis. Atherosclerosis 2008; 198: 332-7.
2. Van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser M, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 2009; 68: 1395-400.
3. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481-94. (Pubitemid 24115934)
4. Gonzalez-Gay MA, Gonzalez-Juanatey C, Miranda-Filloy JA, Garcia-Porrua C, Llorca J, Martin J,. Cardiovascular disease in rheumatoid arthritis. Biomed Pharmacother 2006; 60: 673-77.
5. Ross R,. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-26.
6. Victor VM, Rocha M, Sola E, Banuls C, Garcia-Malpartida K, Hernandez-Mijares A,. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des 2009; 15: 2988-3002.
7. Gonzalez MA, Selwyn AP,. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 2003; 115 Suppl 8A: 99-106S.
8. Ku IA, Imboden JB, Hsue PY, Ganz P,. Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis. Circ J 2009; 73: 977-85.
9. Huang PL,. Endothelial nitric oxide synthase and endothelial dysfunction. Curr Hypertens Rep 2003; 5: 473-80. (Pubitemid 38898972)
10. Tain YL,. Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency. Acta Paediatr Taiwan 2007; 48: 246-50.
11. Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T,. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 2008; 10: 1115-26. (Pubitemid 351451710)
12. Haruna Y, Morita Y, Komai N, Yada T, Sakuta T, Tomita N, et al. Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase. Arthritis Rheum 2006; 54: 1847-55. (Pubitemid 43877934)
13. Haruna Y, Morita Y, Yada T, Satoh M, Fox DA, Kashihara N,. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis. Arthritis Rheum 2007; 56: 1827-35. (Pubitemid 47110382)
14. Sakuta T, Morita Y, Satoh M, Fox DA, Kashihara N,. Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers. Arthritis Rheum 2010; 62: 1319-28.
15. Can C, Cinar M, Kosay S, Evinc A,. Vascular endothelial dysfunction associated with elevated serum homocysteine levels in rat adjuvant arthritis: effect of vitamin E administration. Life Sci 2002; 71: 401-10. (Pubitemid 34614542)
16. Cinar MG, Can C, Ulker S, Gok S, Coker C, Soykan N, et al. Effect of vitamin E on vascular responses of thoracic aorta in rat experimental arthritis. Gen Pharmacol 1998; 31: 149-53. (Pubitemid 28239771)
17. Jenkinson CP, Grody WW, Cederbaum SD,. Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol 1996; 114: 107-32. (Pubitemid 26234050)
18. G-hydroxy-L- arginine during high-output NO production. Am J Physiol 1996; 271: 1988-98.
19. Demougeot C, Prigent-Tessier A, Marie C, Berthelot A,. Arginase inhibition reduced endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats. J Hypertens 2005; 23: 971-8. (Pubitemid 40637915)
20. Demougeot C, Prigent-Tessier A, Bagnost T, Andre C, Guillaume Y, Bouhaddi M, et al. Time course of vascular arginase expression and activity in spontaneously hypertensive rats. Life Sci 2007; 80: 1128-34. (Pubitemid 46241221)
21. Yang Z, Ming XF,. Endothelial arginase: a new target in atherosclerosis. Curr Hypertens Rep 2006; 8: 54-9.
22. Romero MJ, Platt DH, Tawfik HE, Labazi M, El-Remessy AB, Bartoli M, et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 2008; 102: 95-102.
23. Bivalacqua TJ, Hellstrom WJ, Kadowitz PJ, Champion HC,. Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun 2001; 283: 923-7. (Pubitemid 32924668)
24. Katusic ZS,. Mechanisms of endothelial dysfunction induced by aging: role of arginase I. Circ Res 2007; 101: 640-1. (Pubitemid 47494091)
25. Chicoine LG, Paffett ML, Young TL, Nelin LD,. Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol 2004; 287: L60-8. (Pubitemid 38787651)
26. Nelin LD, Chicoine LG, Reber KM, English BK, Young TL, Liu Y,. Cytokine-induced endothelial arginase expression is dependent on epidermal growth factor receptor. Am J Respir Cell Mol Biol 2005; 33: 394-401. (Pubitemid 41416290)
27. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003; 426: 454-60. (Pubitemid 37490133)
28. Corraliza IM, Campo ML, Soler G, Modolell M,. Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 1994; 174: 231-35. (Pubitemid 24297154)
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ,. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
30. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Martin J, Llorca J,. Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum 2008; 38: 67-70.
31. Brahn E,. Animal models of rheumatoid arthritis: clues to etiology and treatment. Clin Orthop Relat Res 1991; 265: 42-53.
32. Hegen M, Keith JC Jr, Collins M, Nickerson-Nutter CL,. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis 2008; 67: 1505-15.
33. Fang ZY, Fontaine J, Unger P, Berkenboom G,. Alterations of the endothelial function of isolated aortae in rats with adjuvant arthritis. Arch Int Pharmacodyn Ther 1991; 311: 122-30.
34. Egan C, Lockhart J, Ferrell W,. Pathophysiology of vascular dysfunction in a rat model of chronic joint inflammation. J Physiol 2004; 557: 635-43. (Pubitemid 38807399)
35. Ulker S, Onal A, Hatip FB, Surucu A, Alkanat M, Kosay S, et al. Effect of nabumetone treatment on vascular responses of the thoracic aorta in rat experimental arthritis. Pharmacology 2000; 60: 136-42. (Pubitemid 30189527)
36. Nozaki K, Goto H, Nakagawa T, Hikiami H, Koizumi K, Shibahara N, et al. Effects of keishibukuryogan on vascular function in adjuvant-induced arthritis rats. Biol Pharm Bull 2007; 30: 1042-7. (Pubitemid 46883865)
37. Maki-Petaja KM, Cheriyan J, Booth AD, Hall FC, Brown J, Wallace SM, et al. Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction. Int J Cardiol 2008; 129: 399-405.
38. Syngle A, Vohra K, Kaur L, Sharma S,. Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis. Scand J Rheumatol 2009; 38: 15-22.
39. Kerekes G, Szekanecz Z, Der H, Sandor Z, Lakos G, Muszbek L, et al. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 2008; 35: 398-406. (Pubitemid 351374411)
40. Bilsborough W, Keen H, Taylor A, O'Driscoll GJ, Arnolda L, Green DJ,. Anti-tumour necrosis factor-α therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. Rheumatol Int 2006; 26: 1125-31. (Pubitemid 44450849)
41. Gao X, Xu X, Belmadani S, Park Y, Tang Z, Feldman AM, et al. TNF-α contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2007; 27: 1269-75. (Pubitemid 46809414)
42. 2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun 1995; 206: 667-73.
43. Louis CA, Mody V, Henry WL Jr, Reichner JS, Albina JE,. Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages. Am J Physiol 1999; 276: 237-42.
44. Eleftheriadis T, Liakopoulos V, Antoniadi G, Stefanidis I, Galaktidou G,. Arginase type I as a marker of coronary heart disease in hemodialysis patients. Int Urol Nephrol 2010. E-pub ahead of print.
45. Matthiesen S, Lindemann D, Warnken M, Juergens UR, Racke K,. Inhibition of NADPH oxidase by apocynin inhibits lipopolysaccharide (LPS) induced up-regulation of arginase in rat alveolar macrophages. Eur J Pharmacol 2008; 579: 403-10.
46. Kim JH, Bugaj LJ, Oh YJ, Bivalacqua TJ, Ryoo S, Soucy KG, et al. Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats. J Appl Physiol 2009; 107: 1249-57.
47. Santhanam L, Lim HK, Lim HK, Miriel V, Brown T, Patel M, et al. Inducible NO synthase-dependent S-nitrosylation and activation of arginase 1 contribute to age-related endothelial dysfunction. Circ Res 2007; 101: 692-702. (Pubitemid 47494100)
48. Huynh NN, Harris EE, Chin-Dusting JF, Andrews KL,. The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries. Br J Pharmacol 2009; 156: 84-93.
49. Santhanam L, Christianson DW, Nyhan D, Berkowitz DE,. Arginase and vascular aging. J Appl Physiol 2008; 105: 1632-42.